Clinical Trial Update: PuraBond® and Pain Following Resection of Oral or Oropharyngeal Mucosal Lesions [NA]

View source ↗

Summary

Completed clinical trial update for PuraBond assessing its use after resection of oral or oropharyngeal mucosal lesions, focusing on pain and hemorrhage outcome…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Cancer
• Oropharyngeal Cancer

Drugs mentioned

• PuraBond

Snippet

Sponsor: University of Liverpool | Conditions: Pain, Hemorrhage | NA | Status: COMPLETED | Results posted: 2025-09-16